Amin DN - Search Results

1

Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.

Coma S, Amin DN, Shimizu A, Lasorella A, Iavarone A, Klagsbrun M. Coma S, et al. Among authors: amin dn. Cancer Res. 2010 May 1;70(9):3823-32. doi: 10.1158/0008-5472.CAN-09-3048. Epub 2010 Apr 13. Cancer Res. 2010. PMID: 20388805 Free PMC article.

2

Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors.

Amin DN, Hida K, Bielenberg DR, Klagsbrun M. Amin DN, et al. Cancer Res. 2006 Feb 15;66(4):2173-80. doi: 10.1158/0008-5472.CAN-05-3387. Cancer Res. 2006. PMID: 16489018

3

Tumor-associated endothelial cells with cytogenetic abnormalities.

Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, Morton CC, Klagsbrun M. Hida K, et al. Among authors: amin dn. Cancer Res. 2004 Nov 15;64(22):8249-55. doi: 10.1158/0008-5472.CAN-04-1567. Cancer Res. 2004. PMID: 15548691

4

Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells.

Amin DN, Bielenberg DR, Lifshits E, Heymach JV, Klagsbrun M. Amin DN, et al. Microvasc Res. 2008 May;76(1):15-22. doi: 10.1016/j.mvr.2008.01.002. Epub 2008 Mar 18. Microvasc Res. 2008. PMID: 18440031

5

HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy.

Campbell MR, Amin D, Moasser MM. Campbell MR, et al. Clin Cancer Res. 2010 Mar 1;16(5):1373-83. doi: 10.1158/1078-0432.CCR-09-1218. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179223 Free PMC article.

6

Neuregulin-regulated gene expression in mammary carcinoma cells.

Amin DN, Tuck D, Stern DF. Amin DN, et al. Exp Cell Res. 2005 Sep 10;309(1):12-23. doi: 10.1016/j.yexcr.2005.04.034. Exp Cell Res. 2005. PMID: 15963498

7

Resiliency and vulnerability in the HER2-HER3 tumorigenic driver.

Amin DN, Sergina N, Ahuja D, McMahon M, Blair JA, Wang D, Hann B, Koch KM, Shokat KM, Moasser MM. Amin DN, et al. Sci Transl Med. 2010 Jan 27;2(16):16ra7. doi: 10.1126/scitranslmed.3000389. Sci Transl Med. 2010. PMID: 20371474 Free PMC article.

8

The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics.

Amin DN, Campbell MR, Moasser MM. Amin DN, et al. Semin Cell Dev Biol. 2010 Dec;21(9):944-50. doi: 10.1016/j.semcdb.2010.08.007. Epub 2010 Sep 9. Semin Cell Dev Biol. 2010. PMID: 20816829 Free PMC article. Review.

9

HER3 signalling is regulated through a multitude of redundant mechanisms in HER2-driven tumour cells.

Amin DN, Sergina N, Lim L, Goga A, Moasser MM. Amin DN, et al. Biochem J. 2012 Nov 1;447(3):417-25. doi: 10.1042/BJ20120724. Biochem J. 2012. PMID: 22853430 Free PMC article.

10

A TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified Cancers.

Amin DN, Ahuja D, Yaswen P, Moasser MM. Amin DN, et al. Mol Cancer Ther. 2015 Dec;14(12):2805-17. doi: 10.1158/1535-7163.MCT-15-0403. Epub 2015 Oct 5. Mol Cancer Ther. 2015. PMID: 26438156 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters